Overview
Lipids are some of the most clinically important excipients for drug delivery systems and are especially relevant for RNA-based therapies and mRNA vaccines. As a CDMO partner offering end-to-end solutions, Evonik has decades of experience and expertise in every step of the manufacturing process, including route scouting, process development and optimization, purification, isolation, characterization, scale-up, and commercialization.
This workshop will focus on the growth and use of lipids for drug delivery and provide insight into important steps for success. We will not only outline the role of our novel multivariate models to speed up timelines and increase successful scale-up and transfer to the clinic, but also highlight current advances in leveraging novel lipids, such as randomized PEGs (rPEGs) in LNP-based delivery systems.
Key learnings for participants
- Introduction to capabilities necessary to support lipid development and manufacturing
- Lipid impurities and their impact on therapeutic effectiveness
- LNP formulation opportunities with rPEGs
This event will be jointly hosted by Evonik Health Care and Knauer. We are delighted to welcome our esteemed speakers from Evonik and Knauer, as well as leaders from industry and academia, who will present exciting insights and case studies.
Note: Please fill in your details and click 'Submit' to register for the workshop. Once we have received your registration, we will send you a status notification as soon as possible. Due to the high demand for our workshops, we sometimes need to reject registrations or put you on a waiting list. Workshop materials will be available for download at the end of the workshop. Any photographs taken during the event are the property of Evonik and may be used for promotional purposes.
